Abstract
Hereditary cystatin C amyloid angiopathy (HCCAA) is an autosomal dominant disorder in which a cysteine proteinase inhibitor, cystatin C, is deposited as amyloid fibrils in the cerebral arteries of patients and leads to massive brain haemorrhage and death in young adults. A full length cystatin C cDNA probe revealed a mutation in the codon for leucine at position 68 which abolishes an Alu I restriction site in the cystatin C gene of HCCAA patients. The Alu I marker has been used to show that this mutation is transmitted only in affected members of all eight families investigated, and that the mutated cystatin C gene causes HCCAA.
Original language | English |
---|---|
Pages (from-to) | 603-604 |
Journal | The Lancet |
Volume | 332 |
Issue number | 8611 |
DOIs | |
Publication status | Published - 1988 |
Subject classification (UKÄ)
- Pharmacology and Toxicology
- Medicinal Chemistry